Hydrogen sulfide improves cardiomyocytes electrical remodeling post ischemia/reperfusion injury in rats

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 1, 2015, Pages 474-481

  Sun, Ying Gang ^a   Wang, Xin Yan ^b   Chen, Xiu ^a   Shen, Cheng Xing ^a   Li, Yi Gang ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Institute of Health Sciences   (China)

Author keywords

Action potential duration; CSE; Hydrogen sulfide; Ischemia reperfusion; KATP channels; L type Ca2+ channels

Indexed keywords

HYDROGEN SULFIDE;

ANIMAL; DRUG EFFECTS; HEART; HEART ATRIUM REMODELING; HEART MUSCLE CELL; MALE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; ATRIAL REMODELING; HEART; HYDROGEN SULFIDE; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; RATS; RATS, WISTAR;

EID: 84923072306     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Calvert JW, Coetzee WA and Lefer DJ. Novel insights into hydrogen sulfide--mediated cytoprotection. Antioxid Redox Signal 2010; 12: 1203-1217.
2. Martelli A, Testai L, Breschi MC, Blandizzi C, Virdis A, Taddei S and Calderone V. Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev 2012; 32: 1093-1130.
3. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007; 6: 917-935.
4. Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang Y, Du J and Tang C. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 2004; 318: 756-763.
5. Yong QC, Lee SW, Foo CS, Neo KL, Chen X and Bian JS. Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning. Am J Physiol Heart Circ Physiol 2008; 295: H1330-H1340.
6. Shi YX, Chen Y, Zhu YZ, Huang GY, Moore PK, Huang SH, Yao T and Zhu YC. Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2007; 293: H2093-2100.
7. Zhao W, Zhang J, Lu Y and Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. Embo J 2001; 20: 6008-6016.
8. Zhu YZ, Wang ZJ, Ho P, Loke YY, Zhu YC, Huang SH, Tan CS, Whiteman M, Lu J and Moore PK. Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. J Appl Physiol (1985) 2007; 102: 261-268.
9. Kondo K, Bhushan S, King AL, Prabhu SD, Hamid T, Koenig S, Murohara T, Predmore BL, Gojon G Sr, Gojon G Jr, Wang R, Karusula N, Nicholson CK, Calvert JW and Lefer DJ. H(2)S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase. Circulation 2013; 127: 1116-1127.
10. Ghuran AV and Camm AJ. Ischaemic heart disease presenting as arrhythmias. Br Med Bull 2001; 59: 193-210.
11. Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S and Moore PK. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 2006; 316: 670-678.
12. Bian JS, Pei JM, Cheung CS, Zhang WM and Wong TM. kappa-opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+) exchange pathway. J Mol Cell Cardiol 2000; 32: 1415-1427.
13. Liu S, Melchert RB and Kennedy RH. Inhibition of L-type Ca2+ channel current in rat ventricular myocytes by terfenadine. Circ Res 1997; 81: 202-210.
14. Oketani N, Kakei M, Ichinari K, Okamura M, Miyamura A, Nakazaki M, Ito S and Tei C. Regulation of K(ATP) channels by P(2Y) purinoceptors coupled to PIP(2) metabolism in guinea pig ventricular cells. Am J Physiol Heart Circ Physiol 2002; 282: H757-765.
15. Cutler MJ, Jeyaraj D and Rosenbaum DS. Cardiac electrical remodeling in health and disease. Trends Pharmacol Sci 2011; 32: 174-180.
16. Pan LL, Liu XH, Gong QH, Yang HB and Zhu YZ. Role of cystathionine gamma-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy? Antioxid Redox Signal 2012; 17: 106-118.
17. King AL, Polhemus DJ, Bhushan S, Otsuka H, Kondo K, Nicholson CK, Bradley JM, Islam KN, Calvert JW, Tao YX, Dugas TR, Kelley EE, Elrod JW, Huang PL, Wang R and Lefer DJ. Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent. Proc Natl Acad Sci U S A 2014; 111: 3182-3187.
18. Sivarajah A, McDonald MC and Thiemermann C. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock 2006; 26: 154-161.
19. Calvert JW, Elston M, Nicholson CK, Gundewar S, Jha S, Elrod JW, Ramachandran A and Lefer DJ. Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice. Circulation 2010; 122: 11-19.
20. Spragg DD, Akar FG, Helm RH, Tunin RS, Tomaselli GF and Kass DA. Abnormal conduction and repolarization in late-activated myocardium of dyssynchronously contracting hearts. Cardiovasc Res 2005; 67: 77-86.
21. Gross GJ and Fryer RM. Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ Res 1999; 84: 973-979.
22. Cole WC, McPherson CD and Sontag D. ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991; 69: 571-581.
23. Pan TT, Feng ZN, Lee SW, Moore PK and Bian JS. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. J Mol Cell Cardiol 2006; 40: 119-130.
24. Ji Y, Pang QF, Xu G, Wang L, Wang JK and Zeng YM. Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Eur J Pharmacol 2008; 587: 1-7.
25. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G and Wang Z. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007; 13: 486-491.
26. Sun YG, Cao YX, Wang WW, Ma SF, Yao T and Zhu YC. Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes. Cardiovasc Res 2008; 79: 632-641.